Cargando…

Seroprevalence of Entamoeba histolytica at a voluntary counselling and testing centre in Tokyo: a cross-sectional study

BACKGROUND: Amebiasis, which is caused by Entamoeba histolytica, is a re-emerging public health issue owing to sexually transmitted infection (STI) in Japan. However, epidemiological data are quite limited. METHODS: To reveal the relative prevalence of sexually transmitted E. histolytica infection t...

Descripción completa

Detalles Bibliográficos
Autores principales: Yanagawa, Yasuaki, Nagashima, Mami, Gatanaga, Hiroyuki, Kikuchi, Yoshimi, Oka, Shinichi, Yokoyama, Keiko, Shinkai, Takayuki, Sadamasu, Kenji, Watanabe, Koji
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7044870/
https://www.ncbi.nlm.nih.gov/pubmed/32102805
http://dx.doi.org/10.1136/bmjopen-2019-031605
_version_ 1783501658429325312
author Yanagawa, Yasuaki
Nagashima, Mami
Gatanaga, Hiroyuki
Kikuchi, Yoshimi
Oka, Shinichi
Yokoyama, Keiko
Shinkai, Takayuki
Sadamasu, Kenji
Watanabe, Koji
author_facet Yanagawa, Yasuaki
Nagashima, Mami
Gatanaga, Hiroyuki
Kikuchi, Yoshimi
Oka, Shinichi
Yokoyama, Keiko
Shinkai, Takayuki
Sadamasu, Kenji
Watanabe, Koji
author_sort Yanagawa, Yasuaki
collection PubMed
description BACKGROUND: Amebiasis, which is caused by Entamoeba histolytica, is a re-emerging public health issue owing to sexually transmitted infection (STI) in Japan. However, epidemiological data are quite limited. METHODS: To reveal the relative prevalence of sexually transmitted E. histolytica infection to other STIs, we conducted a cross-sectional study at a voluntary counselling and testing (VCT) centre in Tokyo. Seroprevalence of E. histolytica was assessed according to positivity with an ELISA for E. histolytica-specific IgG in serum samples collected from anonymous VCT clients. RESULTS: Among 2083 samples, seropositive rate for E. histolytica was 2.64%, which was higher than that for HIV-1 (0.34%, p<0.001) and comparable to that for syphilis (rapid plasma reagin (RPR) 2.11%, p=0.31). Positivity for Chlamydia trachomatis in urine by transcription-mediated amplification (TMA) was 4.59%. Seropositivity for E. histolytica was high among RPR/Treponema pallidum hemagglutination (TPHA)-positive individuals and it was not different between clients with and without other STIs. Both seropositivity of E. histolytica and RPR were high among male clients. The seropositive rate for anti-E. histolytica antibody was positively correlated with age. TMA positivity for urine C. trachomatis was high among female clients and negatively correlated with age. Regression analysis identified that male sex, older age and TPHA-positive results are independent risk factors of E. histolytica seropositivity. CONCLUSIONS: Seroprevalence of E. histolytica was 7.9 times higher than that of HIV-1 at a VCT centre in Tokyo, with a tendency to be higher among people at risk for syphilis infection. There is a need for education and specific interventions against this parasite, as a potentially re-emerging pathogen.
format Online
Article
Text
id pubmed-7044870
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-70448702020-03-09 Seroprevalence of Entamoeba histolytica at a voluntary counselling and testing centre in Tokyo: a cross-sectional study Yanagawa, Yasuaki Nagashima, Mami Gatanaga, Hiroyuki Kikuchi, Yoshimi Oka, Shinichi Yokoyama, Keiko Shinkai, Takayuki Sadamasu, Kenji Watanabe, Koji BMJ Open Epidemiology BACKGROUND: Amebiasis, which is caused by Entamoeba histolytica, is a re-emerging public health issue owing to sexually transmitted infection (STI) in Japan. However, epidemiological data are quite limited. METHODS: To reveal the relative prevalence of sexually transmitted E. histolytica infection to other STIs, we conducted a cross-sectional study at a voluntary counselling and testing (VCT) centre in Tokyo. Seroprevalence of E. histolytica was assessed according to positivity with an ELISA for E. histolytica-specific IgG in serum samples collected from anonymous VCT clients. RESULTS: Among 2083 samples, seropositive rate for E. histolytica was 2.64%, which was higher than that for HIV-1 (0.34%, p<0.001) and comparable to that for syphilis (rapid plasma reagin (RPR) 2.11%, p=0.31). Positivity for Chlamydia trachomatis in urine by transcription-mediated amplification (TMA) was 4.59%. Seropositivity for E. histolytica was high among RPR/Treponema pallidum hemagglutination (TPHA)-positive individuals and it was not different between clients with and without other STIs. Both seropositivity of E. histolytica and RPR were high among male clients. The seropositive rate for anti-E. histolytica antibody was positively correlated with age. TMA positivity for urine C. trachomatis was high among female clients and negatively correlated with age. Regression analysis identified that male sex, older age and TPHA-positive results are independent risk factors of E. histolytica seropositivity. CONCLUSIONS: Seroprevalence of E. histolytica was 7.9 times higher than that of HIV-1 at a VCT centre in Tokyo, with a tendency to be higher among people at risk for syphilis infection. There is a need for education and specific interventions against this parasite, as a potentially re-emerging pathogen. BMJ Publishing Group 2020-02-25 /pmc/articles/PMC7044870/ /pubmed/32102805 http://dx.doi.org/10.1136/bmjopen-2019-031605 Text en © Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.
spellingShingle Epidemiology
Yanagawa, Yasuaki
Nagashima, Mami
Gatanaga, Hiroyuki
Kikuchi, Yoshimi
Oka, Shinichi
Yokoyama, Keiko
Shinkai, Takayuki
Sadamasu, Kenji
Watanabe, Koji
Seroprevalence of Entamoeba histolytica at a voluntary counselling and testing centre in Tokyo: a cross-sectional study
title Seroprevalence of Entamoeba histolytica at a voluntary counselling and testing centre in Tokyo: a cross-sectional study
title_full Seroprevalence of Entamoeba histolytica at a voluntary counselling and testing centre in Tokyo: a cross-sectional study
title_fullStr Seroprevalence of Entamoeba histolytica at a voluntary counselling and testing centre in Tokyo: a cross-sectional study
title_full_unstemmed Seroprevalence of Entamoeba histolytica at a voluntary counselling and testing centre in Tokyo: a cross-sectional study
title_short Seroprevalence of Entamoeba histolytica at a voluntary counselling and testing centre in Tokyo: a cross-sectional study
title_sort seroprevalence of entamoeba histolytica at a voluntary counselling and testing centre in tokyo: a cross-sectional study
topic Epidemiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7044870/
https://www.ncbi.nlm.nih.gov/pubmed/32102805
http://dx.doi.org/10.1136/bmjopen-2019-031605
work_keys_str_mv AT yanagawayasuaki seroprevalenceofentamoebahistolyticaatavoluntarycounsellingandtestingcentreintokyoacrosssectionalstudy
AT nagashimamami seroprevalenceofentamoebahistolyticaatavoluntarycounsellingandtestingcentreintokyoacrosssectionalstudy
AT gatanagahiroyuki seroprevalenceofentamoebahistolyticaatavoluntarycounsellingandtestingcentreintokyoacrosssectionalstudy
AT kikuchiyoshimi seroprevalenceofentamoebahistolyticaatavoluntarycounsellingandtestingcentreintokyoacrosssectionalstudy
AT okashinichi seroprevalenceofentamoebahistolyticaatavoluntarycounsellingandtestingcentreintokyoacrosssectionalstudy
AT yokoyamakeiko seroprevalenceofentamoebahistolyticaatavoluntarycounsellingandtestingcentreintokyoacrosssectionalstudy
AT shinkaitakayuki seroprevalenceofentamoebahistolyticaatavoluntarycounsellingandtestingcentreintokyoacrosssectionalstudy
AT sadamasukenji seroprevalenceofentamoebahistolyticaatavoluntarycounsellingandtestingcentreintokyoacrosssectionalstudy
AT watanabekoji seroprevalenceofentamoebahistolyticaatavoluntarycounsellingandtestingcentreintokyoacrosssectionalstudy